JUNE 11, 2019
Joachim Brunner Interview with Allen Davidoff
XORTX Therapeutics (CSE:XRX; OTCQB:XRTXF) is pleased to share a recent interview with Allen Davidoff, CEO of XORTX by Joachim Brunner. Joachim Brunner, MBA, is a consultant for the PI Value Growth Fund, PI Flexibel Plus and managing director of asset management Portfolio Invest Vermögensmanagement GmbH in Salzburg.
Please note that the introduction to this interview is in German, followed by English.
JUNE 4, 2019 – BIOTUESDAYS, Leonard Zehr
XORTX awaiting key clinical milestones in treating progressive kidney diseases
XORTX Therapeutics (CSE:XRX; OTCQB:XRTXF) is awaiting several key milestones during the next few months as it works to redefine how progressive kidney disease is treated… Read the full article from BIOTUESDAYS here (PDF).